Skip to content
CorpDev.Org

CorpDev.Org

Daily News for Dealmakers

Thursday 10th July 2025
  • Hire Me for M&A/PE Projects!
  • AI Assisted Due Diligence
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities
CorpDev.Org

CorpDev.Org

Daily News for Dealmakers

  • Hire Me for M&A/PE Projects!
  • AI Assisted Due Diligence
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities

Day: July 9, 2025

Private Equity Titans Circle Astorg’s €5 Billion Fund Services Powerhouse IQ-EQ

Private Equity Titans Circle Astorg’s €5 Billion Fund Services Powerhouse IQ-EQ

  • July 9, 2025
  • 0 Comments
  • By CorpDev
Astorg Partners is preparing a potential 2025 exit of IQ-EQ, its crown jewel investor services platform, in a deal that could value the business at €4-5 billion . The Luxembourg-based...
Posted in Private Equity
Hims & Hers’ Strategic Expansion into Canada: Leveraging ZAVA Acquisition and Generic Semaglutide for Market Disruption

Hims & Hers’ Strategic Expansion into Canada: Leveraging ZAVA Acquisition and Generic Semaglutide for Market Disruption

  • July 9, 2025
  • 0 Comments
  • By CorpDev
Hims & Hers Health's planned 2026 Canadian expansion represents a pivotal strategic shift, combining its recent acquisition of European digital health platform ZAVA with the anticipated launch of...
Posted in Healthcare and Life Sciences
Starbucks China Stake Sale: Private Equity Bids Signal Strategic Pivot in $10 Billion Valuation Play

Starbucks China Stake Sale: Private Equity Bids Signal Strategic Pivot in $10 Billion Valuation Play

  • July 9, 2025
  • 0 Comments
  • By CorpDev
Starbucks' China division has attracted nearly 30 non-binding bids valuing the unit at up to $10 billion, with private equity giants Centurium Capital, Hillhouse Capital, Carlyle Group, and KKR...
Posted in Consumer and Industrial
Merck’s $10 Billion Verona Pharma Acquisition: Strategic Masterstroke in the COPD Therapeutics Revolution

Merck’s $10 Billion Verona Pharma Acquisition: Strategic Masterstroke in the COPD Therapeutics Revolution

  • July 9, 2025
  • 0 Comments
  • By CorpDev
The pharmaceutical industry witnessed a landmark transaction on July 9, 2025, as Merck & Co. announced its definitive agreement to acquire Verona Pharma for approximately $10 billion, securing...
Posted in Healthcare and Life Sciences

CorpDev.Org

24×7 real time deals updates for everyone associated with deals.  Bookmark the page!

Daily M&A/PE News In 5 Min

Recent Posts

  • Private Equity Titans Circle Astorg’s €5 Billion Fund Services Powerhouse IQ-EQ
  • Hims & Hers’ Strategic Expansion into Canada: Leveraging ZAVA Acquisition and Generic Semaglutide for Market Disruption
  • Starbucks China Stake Sale: Private Equity Bids Signal Strategic Pivot in $10 Billion Valuation Play
  • Merck’s $10 Billion Verona Pharma Acquisition: Strategic Masterstroke in the COPD Therapeutics Revolution
  • Thoma Bravo’s $2 Billion Acquisition of Olo: Strategic Reshaping of Restaurant Technology

Categories

  • Hire Me for M&A/PE Projects!
  • AI Assisted Due Diligence
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities

Daily M&A/PE News In 5 Min

Deals by month

  • July 2025 (17)
  • June 2025 (161)
  • May 2025 (163)
  • April 2025 (86)
  • January 2025 (53)
  • November 2024 (62)
  • October 2024 (102)
  • September 2024 (97)
  • August 2024 (165)
  • July 2024 (20)
  • March 2023 (7)
  • November 2022 (41)
  • October 2022 (89)
  • September 2022 (190)
  • August 2022 (80)
  • July 2022 (2)
  • June 2022 (79)
  • May 2022 (1)

Copyrights belong to 'Sources' referred to in each article, unless the articles are originally published by CorpDev.org in which case the copyright belongs to CorpDev.org